Search Results - "Keen, Mary"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Poster 128: Ten-year-old girl with heart transplant: a case report by Keen, Mary E.

    “…Setting: Free-standing rehabilitation hospital. Patient: A 10-year-old girl born with truncus arteriosis and who had undergone 4 prior surgeries for complex…”
    Get full text
    Journal Article
  9. 9

    Poster 126: Rickets in a 13-year-old with cerebral palsy by Keen, Mary E.

    “…Setting: A tertiary care hospital. Patient: A 13-year-old boy with cerebral palsy (CP). Case Description: The patient presented with a 2-week history of…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Poster 127: Football player with symptomatic Arnold-chiari malformation: a case report by Keen, Mary E., Gnatz, Steve

    “…Setting: Outpatient physical medicine and rehabilitation clinic. Patient: A 15-year-old football player with arm pain and weakness. Case Description: The…”
    Get full text
    Journal Article
  12. 12

    Solubilization and characterization of high and low affinity pirenzepine binding sites from rat cerebral cortex by Berrie, Christopher P., Birdsall, Nigel J.M., Hulme, Edward C., Keen, Mary, Stockton, Jane M.

    Published in British journal of pharmacology (01-07-1985)
    “…1 An apparently monomeric form of the digitonin‐solubilized muscarinic acetylcholine receptor from the rat cerebral cortex retains a high affinity of 7 × 107…”
    Get full text
    Journal Article
  13. 13

    Testing models of agonism for G protein-coupled receptors by Keen, M

    “…Despite much debate as to the validity of different models of agonism, there is apparently very little to choose between them in practice. However, most…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Desensitization of adenylate cyclase responses following exposure to IP prostanoid receptor agonists. Homologous and heterologous desensitization exhibit the same time course by Krane, A, MacDermot, J, Keen, M

    Published in Biochemical pharmacology (15-03-1994)
    “…Pretreatment of NG108-15 cells with 0.03-25 microM prostaglandin E1 (PGE1) produced decreases in the maximal stimulation of adenylate cyclase activity produced…”
    Get more information
    Journal Article
  16. 16

    An arginyl in the N‐terminus of the V1a vasopressin receptor is part of the conformational switch controlling activation by agonist by Hawtin, Stuart R., Wesley, Victoria J., Simms, John, Parslow, Rosemary A., Miles, Alice, McEwan, Kim, Keen, Mary, Wheatley, Mark

    Published in European journal of biochemistry (01-12-2003)
    “…Defining how the agonist–receptor interaction differs from that of the antagonist–receptor and understanding the mechanisms of receptor activation are…”
    Get full text
    Journal Article
  17. 17

    Inhibition of prostacyclin release from cultured endothelial cells by nitrovasodilator drugs by Matthews, Jane S., McWilliams, Philip J., Key, Brian J., Keen, Mary

    Published in Biochimica et biophysica acta (30-11-1995)
    “…Pretreatment (18 h) of the bovine aortic endothelial cell line AG4762 to 500 μM sodium nitroprusside (SNP), glyceryl trinitrate (GTN) or…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20